Altered Arginine/Nitric Oxide Pathway in Children Diagnosed Attention Deficit Hyperactivity Disorder, and the Effect of 10 Weeks Methylphenidate Treatment
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Objective: In this study, we investigated the levels of arginine, nitric oxide (NO), asymmetric dimethylarginine (ADMA), and adrenomedullin that are presumed to play a role in attention deficit hyperactivity disorder (ADHD) etiology, and to compare the findings with healthy controls. Methods: Thirty ADHD patients and thirty healthy control subjects aged 6−12 years were included in the study. Sociodemographic data form, Schedule for Affective Disorders and Schizophrenia for School Age Children-Present and Lifetime Version; Conners’ Parent/Teacher Rating Scale-Revised: Long Form; Children’s Depression Inventory; and The State-Trait Anxiety Inventory for Children were applied to all cases. All participants included in the study were evaluated in terms of their serum arginine, NO, ADMA, and adrenomedullin levels. Subsequently, methylphenidate treatment was started in ADHD patients and blood parameters were tested again in the tenth week of treatment. Results: At the start of the study, arginine and ADMA levels were significantly higher and NO and adrenomedullin levels were significantly lower in the ADHD group compared to the control group. Post-treatment arginine and ADMA levels were found to be significantly lower than in the pre-treatment period. There were no significant differences in NO and adrenomedullin levels before and after treatment. There was no correlation between scale scores and blood parameters. Conclusion: These variations in the blood parameters of the ADHD group seem to be worth further investigation. Studies to be conducted with larger sample groups after longer-term treatment may provide new information about the alterations in neurobiological processes related to ADHD etiology and treatment.
Abstract
Objective: In this study, we investigated the levels of arginine, nitric oxide (NO), asymmetric dimethylarginine (ADMA), and adrenomedullin that are presumed to play a role in attention deficit hyperactivity disorder (ADHD) etiology, and to compare the findings with healthy controls. Methods: Thirty ADHD patients and thirty healthy control subjects aged 6−12 years were included in the study. Sociodemographic data form, Schedule for Affective Disorders and Schizophrenia for School Age Children-Present and Lifetime Version; Conners’ Parent/Teacher Rating Scale-Revised: Long Form; Children’s Depression Inventory; and The State-Trait Anxiety Inventory for Children were applied to all cases. All participants included in the study were evaluated in terms of their serum arginine, NO, ADMA, and adrenomedullin levels. Subsequently, methylphenidate treatment was started in ADHD patients and blood parameters were tested again in the tenth week of treatment. Results: At the start of the study, arginine and ADMA levels were significantly higher and NO and adrenomedullin levels were significantly lower in the ADHD group compared to the control group. Post-treatment arginine and ADMA levels were found to be significantly lower than in the pre-treatment period. There were no significant differences in NO and adrenomedullin levels before and after treatment. There was no correlation between scale scores and blood parameters. Conclusion: These variations in the blood parameters of the ADHD group seem to be worth further investigation. Studies to be conducted with larger sample groups after longer-term treatment may provide new information about the alterations in neurobiological processes related to ADHD etiology and treatment.
참고문헌 (70)
- Moriyama TS, "IACAPAP e-textbook of child and adolescent mental health", pp.4~13 (2012), International Association for Child and Adolescent Psychiatry and Allied Professions
- Soeters PB, "Quantitative in vivo assessment of arginine utilization and nitric oxide production in endotoxemia", Am J Surg, 183, pp.480~488 (2002)
- Laube G, "Agmatine : multifunctional arginine metabolite and magic bullet in clinical neuroscience?", Biochem J, 474, pp.2619~2640 (2017)
- Yilmaz ED, "Levels of nitric oxide, asymmetric dimethyl arginine, symmetric dimethyl arginine, and L-arginine in patients with obsessive-compulsive disorder", Turk J Med Sci, 46, pp.775~782 (2016)
- Guix FX, "The physiology and pathophysiology of nitric oxide in the brain", Prog Neurobiol, 76, pp.126~152 (2005)
- Herken H, "Adenosine deaminase, nitric oxide, superoxide dismutase, and xanthine oxidase in patients with major depression : impact of antidepressant treatment", Arch Med Res, 38, pp.247~252 (2007)
- Wiesinger H, "Arginine metabolism and the synthesis of nitric oxide in the nervous system", Prog Neurobiol, 64, pp.365~391 (2001)
- Zoroglu SS, "The possible pathophysiological role of plasma nitric oxide and adrenomedullin in schizophrenia", J Psychiatr Res, 36, pp.309~315 (2002)
- Hess S, "Decreased serum L-arginine and L-citrulline levels in major depression", Psychopharmacology(Berl), 234, pp.3241~3247 (2017)
- Sweeten TL, "High nitric oxide production in autistic disorder : a possible role for interferon-gamma", Biol Psychiatry, 55, pp.434~437 (2004)
- Lu YR, "Decreased plasma neuroactive amino acids and increased nitric oxide levels in melancholic major depressive disorder", BMC Psychiatry, 14, pp.123~ (2014)
- Jansen K, "Enhanced nitric oxide(NO)and decreased ADMA synthesis in pediatric ADHD and selective potentiation of NO synthesis by methylphenidate", J Clin Med, 9, pp.175~ (2020)
- Sari SA, "Effects of agmatine, glutamate, arginine, and nitric oxide on executive functions in children with attention deficit hyperactivity disorder", J Neural Transm(Vienna), 127, pp.1675~1684 (2020)
- Gürbüz Özgür B, "The probable role of adrenomedullin and nitric oxide in childhood attention deficit hyperactivity disorder", Nord J Psychiatry, 71, pp.521~524 (2017)
- Avcil S, "Elevated melatonin levels in children with attention deficit hyperactivity disorder : relationship to oxidative and nitrosative stress", J Atten Disord, 25, pp.693~703 (2021)
- Varol Tas F, "Nitric oxide levels in disruptive behavioral disorder", Neuropsychobiology, 53, pp.176~180 (2006)
- Teerlink T, "Cellular ADMA : regulation and action", Pharmacol Res, 60, pp.448~460 (2009)
- Vallance P, "Endogenous dimethylarginine as an inhibitor of nitric oxide synthesis", J Cardiovasc Pharmacol, 12(Suppl 12), pp.S60~S62 (1992)
- Celik C, "Plasma asymmetric dimethylarginine(ADMA)concentrations in patients with first and multiple episode schizophrenia", Psychiatry Res, 190, pp.177~180 (2011)
- Das I, "Elevated endogenous nitric oxide synthase inhibitor in schizophrenic plasma may reflect abnormalities in brain nitric oxide production", Neurosci Lett, 215, pp.209~211 (1996)
- Selley ML, "Increased(E)-4-hydroxy-2-nonenal and asymmetric dimethylarginine concentrations and decreased nitric oxide concentrations in the plasma of patients with major depression", J Affect Disord, 80, pp.249~256 (2004)
- Zincir S, "Asymmetric dimethylarginine(ADMA)and treatment response relationship in male patients with first-episode schizophrenia : a controlled study", Psychiatry Res, 220, pp.76~80 (2014)
- Baranyi A, "Nitric oxide-related biological pathways in patients with major depression", PLoS One, 10, pp.e0143397~ (2015)
- Kato J, "Adrenomedullin : a possible autocrine or paracrine hormone in the cardiac ventricles", Hypertens Res, 26(Suppl), pp.S113~S119 (2003)
- Serrano J, "Adrenomedullin in the central nervous system", Microsc Res Tech, 57, pp.76~90 (2002)
- Hayakawa H, "Role of nitric oxide-cGMP pathway in adrenomedullin-induced vasodilation in the rat", Hypertension, 33, pp.689~693 (1999)
- Nishimatsu H, "Adrenomedullin induces endothelium-dependent vasorelaxation via the phosphatidylinositol 3-kinase", Akt-dependent pathway in rat aorta, 2001, pp.89, 63~70
- Shimekake Y, "Adrenomedullin stimulates two signal transduction pathways, cAMP accumulation and Ca2+ mobilization, in bovine aortic endothelial cells", J Biol Chem, 270, pp.4412~4417 (1995)
- Shan J, "Intracerebroventricular adrenomedullin stimulates the hypothalamic-pituitary-adrenal axis, the sympathetic nervous system and production of hypothalamic nitric oxide", J Neuroendocrinol, 13, pp.975~984 (2001)
- Kaufman J, "Schedule for affective disorders and schizophrenia for school-age children-present and lifetime version(K-SADS-PL) : initial reliability and validity data", J Am Acad Child Adolesc Psychiatry, 36, pp.980~988 (1997)
- Gökler B, "Reliability and validity of schedule for affective disorders and schizophrenia for school age children--present and lifetime version--Turkish version (K-SADS-PL-T)", Çocuk ve Gençlik Ruh Sağliği Dergisi, 11, pp.109~116 (2004)
- Conners CK, "The revised Conners’ Parent Rating Scale(CPRS-R) : factor structure, reliability, and criterion validity", J Abnorm Child Psychol, 26, pp.257~268 (1998)
- Kaner S, "Conners’parent rating scale long form-revised: factor structure, reliability and validity studies", Turk J Child Adolesc Ment Health, 18, pp.45~58 (2011)
- Conners CK, "Revision and restandardization of the Conners Teacher Rating Scale(CTRS-R) : factor structure, reliability, and criterion validity", J Abnorm Child Psychol, 26, pp.279~291 (1998)
- Kaner S, "The validity and reliability study of the Turkish version of Conners’Teacher Rating Scale-Revised (CTRS-R)", Proceedings of World Psychiatric Association International Congress (2006)
- Kovacs M, "Rating scales to assess depression in school-aged children", Acta Paedopsychiatr, 46, pp.305~315 (1981)
- Öy B, "The children’s depression inventory: validity and reliability study", Turk J Psychiatry, 2, pp.132~136 (1991)
- Speilberger C, "State-trait anxiety inventory for children" (1973), Consulting Psychologists Press
- Ozusta HS, "Turkish standardization, reliability and validity of the state-trait anxiety inventory for children", Turk Psikoloji Dergisi, 10, pp.32~44 (1995)
- Guy W, "ECDEU assessment manual for psychopharmacology, revised", pp.218~222 (1976), US Department of Health, Education, and Welfare Publication (ADM)
- Gao Y, "Lack of neuronal nitric oxide synthase results in attention deficit hyperactivity disorder-like behaviors in mice", Behav Neurosci, 129, pp.50~61 (2015)
- Selek S, "Oxidative imbalance in adult attention deficit", hyperactivity disorder, 2008, pp.79, 256~259
- Oztop D, "Oxidative stress in children with attention deficit hyperactivity disorder", Clin Biochem, 45, pp.745~748 (2012)
- Espey MG, "A chemical perspective on the interplay between NO, reactive oxygen species, and reactive nitrogen oxide species", Ann N Y Acad Sci, 962, pp.195~206 (2002)
- Pacher P, "Nitric oxide and peroxynitrite in health and disease", Physiol Rev, 87, pp.315~424 (2007)
- Xing B, "Norepinephrine versus dopamine and their interaction in modulating synaptic function in the prefrontal cortex", Brain Res, 1641(Pt B), pp.217~233 (2016)
- Satoh S, "NO donors stimulate noradrenaline release from rat hippocampus in a calmodulin-dependent manner in the presence of L-cysteine", J Cell Physiol, 169, pp.87~96 (1996)
- dopamine from rat striatum in vitro, "J Neurochem", 1996, 131~137
- Ohkuma S, "Nitric oxide and peroxynitrite as factors to stimulate neurotransmitter release in the CNS", Prog Neurobiol, 64, pp.97~108 (2001)
- Fujiyama F, "Association of dopaminergic terminals and neurons releasing nitric oxide in the rat striatum : an electron microscopic study using NADPH-diaphorase histochemistry and tyrosine hydroxylase immunohistochemistry", Brain Res Bull, 40, pp.121~127 (1996)
- Dawson TM, "Nitric oxide signaling in neurodegeneration and cell death", Adv Pharmacol, 82, pp.57~83 (2018)
- Grammatikopoulos G, "Selective inhibition of neuronal nitric oxide synthesis reduces hyperactivity and increases non-selective attention in the Naples High-Excitability rat", Behav Brain Res, 130, pp.127~132 (2002)
- Carrey NJ, "Striatal creatine and glutamate", glutamine in attention-deficit, J Child Adolesc Psychopharmacol, pp.2007, 17[DOI]
- Huang X, "The role of glutamate receptors in attention-deficit", hyperactivity disorder : from physiology to disease, 2019, pp.180, 272~286
- Kim BN, "Regional cerebral perfusion abnormalities in attention deficit", hyperactivity disorder. Statistical parametric mapping analysis, 2002, pp.252, 219~225
- da Silva N Jr, "Attention deficit", hyperactivity disorder : is there a correlation between dopamine transporter density and cerebral blood flow?, 2011, pp.36, 656~660
- Spalletta G, "Prefrontal blood flow dysregulation in drug naive ADHD children without structural abnormalities", J Neural Transm(Vienna), 108, pp.1203~1216 (2001)
- Kim BN, "Regional differences in cerebral perfusion associated with the alpha-2A-adrenergic receptor genotypes in attention deficit hyperactivity disorder", J Psychiatry Neurosci, 35, pp.330~336 (2010)
- Ma L, "The function of hypothalamus-pituitary-adrenal axis in children with ADHD", Brain Res, 1368, pp.159~162 (2011)
- Lee S, "Nitric oxide stimulates ACTH secretion and the transcription of the genes encoding for NGFI-B, corticotropin-releasing factor, corticotropin-releasing factor receptor type 1, and vasopressin in the hypothalamus of the intact rat", J Neurosci, 19, pp.7640~7647 (1999)
- Virarkar M, "L-arginine and nitric oxide in CNS function and neurodegenerative diseases", Crit Rev Food Sci Nutr, 53, pp.1157~1167 (2013)
- Bain AR, "Insufficient sleep is associated with impaired nitric oxidemediated endothelium-dependent vasodilation", Atherosclerosis, 265, pp.41~46 (2017)
- Cortese S, "Sleep and alertness in children with attention-deficit", hyperactivity disorder : a systematic review of the literature, 2006, pp.29, 504~511
- Konofal E, "Cortese S", Sleep and ADHD Sleep Med, 11, pp.652~658 (2010)
- Figueira L, "Cerebellar adrenomedullinergic system. Role in cardiovascular regulation", Adv Exp Med Biol, 956, pp.541~560 (2017)
- Kohno M, "Inhibition of endothelin production by adrenomedullin in vascular smooth muscle cells", Hypertension, 25, pp.1185~1190 (1995)
- Dogan A, "Intravenous infusion of adrenomedullin and increase in regional cerebral blood flow and prevention of ischemic brain injury after middle cerebral artery occlusion in rats", J Cereb Blood Flow Metab, 17, pp.19~25 (1997)
- Volz TJ, "Methylphenidate analogs with behavioral differences interact differently with arginine residues on the dopamine transporter in rat striatum", Synapse, 57, pp.175~178 (2005)
- Li X, "Proteomic profiling of proteins associated with methamphetamine-induced neurotoxicity in different regions of rat brain", Neurochem Int, 52, pp.256~264 (2008)
- Selek S, "Evaluation of total oxidative status in adult attention deficit hyperactivity disorder and its diagnostic implications", J Psychiatr Res, 46, pp.451~455 (2012)
